COVID-19 Treatment: Updates March 19-24, 2020

,

Strategic Alliance Partners | <b>Society of Infectious Diseases Pharmacists</b>

Erin K. McCreary, PharmD, BCPS, BCIDP; and Jason M. Pogue, PharmD, BCPS, BCIDP, provide an update of published literature on experimental treatments for COVID-19 from the past week.

Clinicians and researchers across the globe are working with fervor to mitigate the world pandemic caused by SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19). New data emerge daily, and it is imperative we embrace a deliberate calm to scrutinize the evidence and report it intentionally, despite our overwhelming desire to find an effective treatment. We previously reviewed published literature on experimental treatments for COVID-19 from December 31, 2019 through March 19, 2020. Here, we provide updates from the past 6 days (!!) as we strive to continually analyze data and optimize patient care. We also encourage readers to check out resources from the Society of Infectious Diseases Pharmacists (SIDP) regarding previously reviewed agents with therapeutic potential for COVID-19.

This content is only available as a PDF.

* McCreary is an active member of the Society of Infectious Diseases Pharmacists and an infectious diseases clinical pharmacy at the University of Pittsburgh Medical Center.

**Pogue is the president of the Society of Infectious Diseases Pharmacist and a clinical professor at the University of Michigan College of Pharmacy.